Visiongain Publishes Hydrophobic Interaction Chromatography Market Report 2021-2031

29 October 2020
Pharma

Visiongain has published a new report on Hydrophobic Interaction Chromatography Market Report : Forecasts by Product & Services (Resin, Columns (Empty, Prepacked), Buffer), Sample (Monoclonal Antibodies, Vaccines), End User (Pharmaceutical Companies, CROs & CMOs, Research Institutes). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Global Hydrophobic Interaction Chromatography market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031. Global Hydrophobic Interaction Chromatography (HIC) is one of the most extensively used methods for splitting and cleansing proteins in their native state. HIC also proves to be quite useful in isolating protein complexes and in studying protein folding and unfolding.

Various products in hydrophobic interaction chromatography market includes resins, buffers, and columns and increasingly being demanded for protein purification applications by pharmaceuticals companies, research institutes, and contract research organisation in various parts of the world. This will drive the market to the growth of this sector.

COVID-19 Impact on Global Hydrophobic Interaction Chromatography Market
In this period of pandemic COViD 19 this market is likely to grow in rapidgrowth rate due to the great demand of several antibodies for many diseases an especially for this pandemic COViD 19. Moreover this pandemic has no specific medicine for this disease so the demand for antibodies is increasing. Hence in this pandemic this market is growing with tremendous speed.

Market Drivers
The rise in demand for monoclonal antibodies in oncology is a key factor driving the demand for HIC separation technique. Rising research and development of monoclonal antibodies for finding efficacious therapies for various diseases is also boosting the market. The growing focus of pharma companies across the globe on therapeutic antibodies has imparted a big fillip to the demand for HIC. The hydrophobic interaction chromatography market is increasingly benefitting rising research and development funding by biopharmaceutical companies in developed regions.

Segment Analysis
In this report, the market has been categorized based on product & service, sample type, end user, and region. The HIC products market includes resins, columns, buffers, and other HIC products. HIC resins are expected to dominate the products market during the forecast period. This segment is also estimated to grow at the highest CAGR during the forecast period owing to the increasing demand for HIC resins for the purification of hydrophobic protein molecules.

On the grounds of sample type, the global hydrophobic interaction chromatography market is classified into monoclonal antibodies, vaccines, and other samples. In 2020, the monoclonal antibodies segment is expected to account for the largest share of the global hydrophobic interaction chromatography market. This large share of this segment is attributed to increasing application of mAbs in autoimmune disorders, CVD, infectious diseases, and cancer and also the current spread of COVID-19 globally.

Competitive Landscape
Some of the companies mentioned-GE Healthcare (US), Bio-Rad laboratories(US), Sartorius(Germany), Thermo Fisher Scientia(US) , Tosoh Corporation (Japan).

Hydrophobic interaction chromatography market is amalgamated in nature with a major share contributed by top companies in this market such as GE Healthcare, Tosoh Corporation, Merck, and Bio-Rad. Positions for this market have been derived on the basis of several features such as segmental revenue, organic and inorganic growth strategies, brand image, product portfolios, product innovation, and regional presence.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

Read

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

Read

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

Read

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever